Gene immunization for allergic disorders.
Roman
M
M
Dynavax Technologies Corporation, San Diego, CA 92121, USA.
Spiegelberg
H L
HL
Broide
D
D
Raz
E
E
D000485:Allergens / Q000009:adverse effects / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use; D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D004247:DNA / Q000276:immunology; D003888:Desensitization, Immunologic; D004802:Eosinophilia / Q000517:prevention & control; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000517:prevention & control*; D007114:Immunization; D007073:Immunoglobulin E / Q000096:biosynthesis / Q000276:immunology; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D051379:Mice; D051381:Rats; D012130:Respiratory Hypersensitivity / Q000517:prevention & control; D016176:T-Lymphocyte Subsets / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology
D000485:Allergens; D016207:Cytokines; D007074:Immunoglobulin G; D019444:Vaccines, DNA; D007073:Immunoglobulin E; D004247:DNA